0

Preliminary Results from Genzyme’s Pivotal 1602 Study

Author: 
Genzyme
Category: Archive
Published
April 27, 2005

The 1602 study was a clinical trial done to test the safety and efficacy of Myozyme in the infantile Pompe patient population.

Back to news articles